High-affinity interaction of (des-tyrosyl)dynorphin A(2-17) with NMDA receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 760-765

  Tang, Qingbo ^a   Gandhoke, Ronnie ^a   Burritt, Andrew ^b   Hruby, Victor J ^b   Porreca, Frank ^a   Lai, Josephine ^a,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; DYNORPHIN A; DYNORPHIN A DERIVATIVE; DYNORPHIN[2-17][DESTYROSINE]; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; EMBRYO; HUMAN; HUMAN CELL; LIGAND BINDING; MOTOR DYSFUNCTION; NEUROTOXICITY; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; TAIL FLICK TEST;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; CEREBRAL CORTEX; DIZOCILPINE MALEATE; DYNORPHINS; EMBRYO; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KIDNEY; MALE; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMINO ACID; TIME FACTORS;

EID: 0032741184     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bakshi R and Faden AI (1990) Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res 507:1-5.
2. 125I-containing acylating agent. Biochem J 133:529-539.
3. Brauneis U, Oz M, Peoples RW, Weight FF and Zhang L (1996) Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin. J Pharmacol Exp Ther 279:1063-1068.
4. Caudle RM and Isaac L (1987) Intrathecal dynorphin(1-13) results in an irreversible loss of tail-flick reflex in rats. Brain Res 435:1-6.
5. Chavkin C, James IF and Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science (Wash DC) 215:413-415.
6. Chen L, Gu Y and Huang LM (1995) The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J Neurosci 15:4602-4611.
7. Drasci G, Kajander KC, Dubner R, Bennett GJ and Iadarola MJ (1991) Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res 560:186-192.
8. 3H]CGP39,653 binding to rat brain membranes. Eur J Pharmacol 271:241-244.
9. Faden AI (1992) Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J Neurosci 12:425-429.
10. Kajander KC, Sahara Y, Iadarola MJ and Bennett GJ (1990) Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides 11:719-728.
11. Long JB, Rigamonti DD, Oleshanky MA, Wingfield CP, and Martinez-Arizala A (1994) Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J Pharmacol Exp Ther 269:358-366.
12. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin reagent. J Biol Chem 193:265-275.
13. Massardier D and Hunt PF (1989) A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor. Eur J Pharmacol 170:125-126.
14. Nichols ML, Lopez Y, Ossipov MH, Bian D and Porreca F (1997) Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A(1-13) or MK-801 in nerve-ligation model of peripheral neuropathy. Pain 69:317-322.
15. Quillan JM and Sadee W (1997) Dynorphin peptides: Antagonists of melanocortin receptors. Pharmaceutical Res 14:713-719.
16. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem 51:830-836.
17. Reynolds IJ and Miller RJ (1989) Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: Interaction with polyamines. Mol Pharmacol 36:758-765.
18. Shukla VK, Bansinath M, Dumont M and Lemaire S (1992) Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pro. Brain Res 591:176-180.
19. Walker JM, Moises HC, Coy DH, Baldrighi G and Akil H (1982) Non-opioid effects of dynorphin and des-tyr-dynorphin. Science (Wash DC) 218:1136-1138.
20. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274-281.
21. Zhang L, Peoples RW, Oz M, Harvey-White J, Weight FF and Brauneis U (1997) Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations. J Neurophysiol 78:582-590.